Currently holds positions in DexCom Inc, AxoGen Inc and Alphatec Holdings Inc
Position | Company | Period |
---|---|---|
Chief Financial Officer, Chief Operating Officer | DexCom Inc | Oct. 1, 2019 - |
Director | AxoGen Inc | May 15, 2019 - |
Independent Director | Alphatec Holdings Inc | Oct. 1, 2017 - |
Chief Financial Officer, Executive Vice President | DexCom Inc | Sept. 1, 2017 - Oct. 1, 2019 |
Chief Financial Officer, Executive Vice President Head of Strategy and Corporate Integrity | NuVasive Inc | Aug. 1, 2014 - Aug. 25, 2017 |
Executive Vice President - Finance and Investor Relations | NuVasive Inc | Feb. 1, 2014 - Aug. 1, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-08 | 2024-03-07 |
Alphatec Holdings Inc
(ATEC)
|
B Purchase |
20,000
+3.6%
12.83256,600 USD |
20,000 +3.6% | 12.83 | 256,600 USD | |
2024-03-01 | 2024-02-29 |
iRhythm Technologies Inc
(IRTC)
|
S Sale |
24,701
-12.1%
121.963,012,534 USD |
24,701 -12.1% | 121.96 | 3,012,534 USD | |
2022-11-04 | 2022-11-02 |
iRhythm Technologies Inc
(IRTC)
|
S Sale |
12,415
-12.2%
122.501,520,838 USD |
12,415 -12.2% | 122.50 | 1,520,838 USD | |
2022-11-04 | 2022-11-02 |
iRhythm Technologies Inc
(IRTC)
|
S Sale |
284
-0.3%
118.1733,560 USD |
284 -0.3% | 118.17 | 33,560 USD | |
2021-03-12 | 2021-03-10 |
DexCom Inc
(DXCM)
|
S Sale |
6,509
-12.6%
362.222,357,688 USD |
6,509 -12.6% | 362.22 | 2,357,688 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
PS Planned sale |
171
-0.4%
405.3369,311 USD |
171 -0.4% | 405.33 | 69,311 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
PS Planned sale |
272
-0.6%
403.87109,854 USD |
272 -0.6% | 403.87 | 109,854 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
PS Planned sale |
2,159
-4.6%
402.72869,471 USD |
2,159 -4.6% | 402.72 | 869,471 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
PS Planned sale |
3,157
-6.3%
401.791,268,455 USD |
3,157 -6.3% | 401.79 | 1,268,455 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
PS Planned sale |
3,017
-5.7%
399.911,206,536 USD |
3,017 -5.7% | 399.91 | 1,206,536 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
PS Planned sale |
1,594
-2.9%
398.98635,978 USD |
1,594 -2.9% | 398.98 | 635,978 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
PS Planned sale |
1,300
-2.3%
397.76517,090 USD |
1,300 -2.3% | 397.76 | 517,090 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
PS Planned sale |
523
-0.9%
397.03207,647 USD |
523 -0.9% | 397.03 | 207,647 USD | |
2020-09-11 | 2020-09-09 |
DexCom Inc
(DXCM)
|
S Sale |
1,579
-2.7%
398.30628,919 USD |
1,579 -2.7% | 398.30 | 628,919 USD | |
2020-09-11 | 2020-09-09 |
DexCom Inc
(DXCM)
|
S Sale |
3,297
-5.4%
398.301,313,202 USD |
3,297 -5.4% | 398.30 | 1,313,202 USD | |
2020-09-11 | 2020-09-09 |
DexCom Inc
(DXCM)
|
S Sale |
8,010
-11.6%
398.303,190,399 USD |
8,010 -11.6% | 398.30 | 3,190,399 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
PS Planned sale |
100
-0.1%
244.7824,478 USD |
100 -0.1% | 244.78 | 24,478 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
PS Planned sale |
400
-0.6%
244.0197,604 USD |
400 -0.6% | 244.01 | 97,604 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
PS Planned sale |
500
-0.7%
241.06120,532 USD |
500 -0.7% | 241.06 | 120,532 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
PS Planned sale |
1,100
-1.5%
239.63263,596 USD |
1,100 -1.5% | 239.63 | 263,596 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
PS Planned sale |
600
-0.8%
238.29142,972 USD |
600 -0.8% | 238.29 | 142,972 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
PS Planned sale |
641
-0.9%
237.10151,980 USD |
641 -0.9% | 237.10 | 151,980 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
PS Planned sale |
472
-0.6%
235.90111,344 USD |
472 -0.6% | 235.90 | 111,344 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
PS Planned sale |
300
-0.4%
234.2370,270 USD |
300 -0.4% | 234.23 | 70,270 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
PS Planned sale |
200
-0.3%
232.0046,400 USD |
200 -0.3% | 232.00 | 46,400 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
PS Planned sale |
200
-0.3%
228.8645,772 USD |
200 -0.3% | 228.86 | 45,772 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
PS Planned sale |
400
-0.5%
227.5691,025 USD |
400 -0.5% | 227.56 | 91,025 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
PS Planned sale |
457
-0.6%
223.62102,196 USD |
457 -0.6% | 223.62 | 102,196 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
S Sale |
200
-0.3%
220.5044,100 USD |
200 -0.3% | 220.50 | 44,100 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
PS Planned sale |
200
-0.3%
219.3743,873 USD |
200 -0.3% | 219.37 | 43,873 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
PS Planned sale |
583
-0.8%
218.84127,582 USD |
583 -0.8% | 218.84 | 127,582 USD | |
2020-03-13 | 2020-03-11 |
DexCom Inc
(DXCM)
|
S Sale |
5,963
-7.3%
265.431,582,735 USD |
5,963 -7.3% | 265.43 | 1,582,735 USD | |
2020-03-13 | 2020-03-11 |
DexCom Inc
(DXCM)
|
S Sale |
129
-0.2%
251.0332,383 USD |
129 -0.2% | 251.03 | 32,383 USD | |
2020-03-13 | 2020-03-11 |
DexCom Inc
(DXCM)
|
S Sale |
116
-0.1%
246.6128,607 USD |
116 -0.1% | 246.61 | 28,607 USD | |
2020-03-10 | 2020-03-09 |
DexCom Inc
(DXCM)
|
PS Planned sale |
891
-1.1%
261.00232,551 USD |
891 -1.1% | 261.00 | 232,551 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
PS Planned sale |
600
-0.9%
144.5786,742 USD |
600 -0.9% | 144.57 | 86,742 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
PS Planned sale |
406
-0.6%
143.5758,288 USD |
406 -0.6% | 143.57 | 58,288 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
PS Planned sale |
1,289
-1.8%
142.16183,247 USD |
1,289 -1.8% | 142.16 | 183,247 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
PS Planned sale |
3,725
-4.9%
141.62527,517 USD |
3,725 -4.9% | 141.62 | 527,517 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
PS Planned sale |
2,500
-3.2%
140.47351,181 USD |
2,500 -3.2% | 140.47 | 351,181 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
PS Planned sale |
1,800
-2.2%
139.29250,716 USD |
1,800 -2.2% | 139.29 | 250,716 USD | |
2019-09-11 | 2019-09-09 |
DexCom Inc
(DXCM)
|
S Sale |
11,049
-12.1%
150.111,658,578 USD |
11,049 -12.1% | 150.11 | 1,658,578 USD | |
2019-09-11 | 2019-09-09 |
DexCom Inc
(DXCM)
|
S Sale |
637
-0.7%
145.4592,654 USD |
637 -0.7% | 145.45 | 92,654 USD | |
2019-05-30 | 2019-05-29 |
DexCom Inc
(DXCM)
|
PS Planned sale |
3,376
-3.5%
119.30402,762 USD |
3,376 -3.5% | 119.30 | 402,762 USD | |
2019-05-30 | 2019-05-29 |
DexCom Inc
(DXCM)
|
PS Planned sale |
5,498
-5.5%
118.73652,765 USD |
5,498 -5.5% | 118.73 | 652,765 USD | |
2019-03-13 | 2019-03-12 |
DexCom Inc
(DXCM)
|
S Sale |
5,358
-5.1%
142.79765,081 USD |
5,358 -5.1% | 142.79 | 765,081 USD | |
2018-09-12 | 2018-09-10 |
DexCom Inc
(DXCM)
|
S Sale |
7,149
-7.0%
143.761,027,706 USD |
7,149 -7.0% | 143.76 | 1,027,706 USD |